Amy Guise, MD
Urology · Milwaukee, WINPI 1114087640
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $77,513 of the $105,768 with a category attached, or 73.3%. Boston Scientific accounts for 95.1% of it on its own, with 4 other manufacturers making up the rest. Among urology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $826.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$101K
- Coloplast$5K
- Agiliti Surgical, Inc.$59
- Antares Pharma, Inc.$50
- Pfizer$15
Across 6 payments — averaging $1547.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$9K
What the payments were for
- Consulting fees$10,35010%
- Speaking & faculty fees$77,51373%
- Travel & lodging$9,4629%
- Food & beverage$3,4603%
- Education$4,9835%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 110 | $100,538 |
| Coloplast | 15 | $5,107 |
| Agiliti Surgical, Inc. | 1 | $59 |
| Antares Pharma, Inc. | 1 | $50 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTRA$28,700
- AMS$25,287
- AdVance XP$14,163
- TITAN$4,915
- ADVANCE$4,500
- GENERAL - THERAPIES$2,863
- AMS 700$1,952
- Lumenis Pulse 120H$146
How this compares
$105,768 in reported general payments places this provider in the 95th percentile of 215 urology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 163 | $127,772 |
| GemtesaVibegron | 23 | $19,256 |
| Mirabegron ErMirabegron | 12 | $6,270 |
| Trospium Chloride | 72 | $3,895 |
| Solifenacin Succinate | 61 | $3,377 |
| Tamsulosin Hcl | 167 | $3,082 |
| Finasteride | 178 | $2,432 |
| Tolterodine Tartrate ErTolterodine Tartrate | 18 | $1,246 |
| Testosterone | 17 | $803 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 50 | $768 |
| Duloxetine Hcl | 22 | $679 |
| Bethanechol Chloride | 16 | $463 |
| Terazosin Hcl | 14 | $284 |
Paid to pharmacies, not to this prescriber.
Other urology in Milwaukee
- Mark WaplesMilwaukee$15K
- Robert OconnorMilwaukee$12K
- Matthew JohnsonMilwaukee$10K
- Peter LeonoviczMilwaukee$9K
- Arjun SivaramanMilwaukee$8K
- Graham MachenMilwaukee$7K
- Scott JohnsonMilwaukee$6K
- Luriel Smith-HarrisonMilwaukee$5K
- Charles KiddMilwaukee$5K
- Pedro BandaMilwaukee$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.